Serological Transplant Diagnostics Market

Serological Transplant Diagnostics Market Outlook (2021-2031)

The global serological transplant diagnostics market size is gaining traction and likely to ascend at around 2.5% CAGR during the forecast period of 2021 to 2031. While advancements in the medical & diagnostic sector are playing a vital role in raising the market value for serological transplant diagnostics, growing awareness regarding proper diagnosis remains another key growth factor.

The growth potential of the market will be propelled by mergers and acquisitions involving smaller specialized hospitals and Tier-1 hospitals. This trend is anticipated to enhance the value of the serological transplant diagnostics market over the predicted timeframe. Consequently, the demand for transplant diagnostic products, assays, and kits is expected to rise, driven by the increasing number of individuals seeking healthcare services from larger hospitals. These acquisitions also facilitate training opportunities for medical personnel, including physicians and nurses.

Regional players across North America, Europe, and Asia Pacific are set to witness impressive growth over the coming years, while rise in requirement from hospitals and other key distribution channels will further cater market growth in future.

A new study by Fact.MR provides thorough analysis of the global serological transplant diagnostics market, along with insights of key driving & restraining factors, demand-supply trajectories, and new trends around the globe for the forecast period of 2021 to 2031.

The report tracks the industry in 20+high-growth markets, and also details how the COVID-19 pandemic is shaping market growth.

Historical & Future Market Outlook

Serological transplant diagnosis, being a highly significant part of successful and efficient organ transplantation, has gained rapid traction over the past years.

Growth in key distribution channels such as hospitals and organ transplantation centers, to name a few, has further raised demand during the last 5 years from 2016 to 2020, which, in turn, has attracted more stakeholders to this industry.

Rise in cases of serious lung, liver, and kidney diseases, and medical & diagnostic advancements, are fuelling the sales of serological transplant diagnostic equipment.

Additionally, various initiatives taken by leading health organizations such as the WHO (World Health Organization), CDC (Centers for Disease Control and Prevention), and others are aiding the growth of suppliers in this industry.

According to Fact.MR, the global serological transplant diagnostics market is set to expand at around 2.5% CAGR through 2031.

How is Rising Need for Organ Transplants Aiding Demand for Serological Transplant Diagnostics?

Prevalence of organ damage cases has substantially raised the demand for serological transplant diagnostic solutions since the past decade. According to a report published by the National Kidney Foundation, over 2 million people across the world currently receive treatment for kidney failure, while a majority are treated in only five countries - the United States, Japan, Germany, Brazil, and Italy.

As per the report, more than 80% of all patients who receive treatment for kidney failure are from affluent countries, with universal access to healthcare and a large elderly population.

As stated in a report titled “The Burden of Lung Diseases”, published by the ERS Organization, respiratory diseases are among the leading causes of death worldwide, while lung infections, lung cancer, and chronic obstructive pulmonary disease (COPD) together account for approximately 10 million deaths yearly. This indicates the rising need serological transplant diagnostic equipment across regions.

What are the Key Challenges Faced by Serology Transplant Diagnostic Equipment Suppliers?

While cases of kidney, heart, lung, and other organ damage are increasing steadily, there is still lack of knowledge and awareness regarding timely diagnosis and receiving proper treatment.

Furthermore, serological transplantation and diagnosis are quite expensive, and hence, not affordable by everyone.

As stated in a report published by NCBI, liver disease accounts for nearly 2 million deaths per year, worldwide. The fatality of liver, kidney, lung, and other organ damage is well-known, but still, organ transplants are yet to be widely adopted by patients who suffer from severe damage.

Manufacturers and suppliers of serological transplant diagnostics are investing their efforts to produce a broader range of affordable products as a solution to this issue.

Country-Wise Analysis

Why is the Serological Transplant Diagnostics Industry Anticipated to Exhibit Hegemony in the U.S.?

The United States is the leading country in North America as far as serological transplant diagnostics is concerned, and will witness impressive rise in demand over the coming years.

Highly advanced medical & diagnostic sectors coupled with rise in cases of severe kidney and heart diseases are fuelling the sales of manufacturers in the country.

As stated in a report titled “Heart Disease Facts”, published by CDC on 8th September 2020, heart disease cost the United States around US$ 219 billion each year from 2014 to 2015, which includes the cost of healthcare services, medicines, and lost productivity due to health.

As per the report, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States, and around 655,000 Americans die from heart disease, including heart damage, each year. As more people are becoming aware regarding the fatality of heart diseases, the rate of organ transplantation is rising in the U.S.

What Enables China to Maintain a Leading Market Position?

China, being the epicenter of the world’s fastest-growing market for serological transplant diagnostics, East Asia, is in the spotlight for manufacturers and suppliers in this industry.

Highly advanced diagnostics industry, and increase in cases of liver, kidney, and lung damage, are raising the revenue of players in in China.

As per data revealed by the China Governmental Statistical Survey, overall rate of survival in brain-dead donor single lung transplantation is more than 60%, while the same for double lung transplantation is more than 75%, as observed over the last 5 years.

This data gives a glimpse of new growth scope awaiting players dealing with serological transplant diagnostics in China.

How Lucrative Would Germany be for Providers of Serology Transplant Diagnostics?

Germany is the dominating country in Europe for serological transplant diagnostics, owing to surge in demand from highly developed hospitals and blood banks & transportation centers.

Additionally, rise in requirement in diverse applications such as liver transplantation, heart transplantation, and kidney transplantation is further catering to growth of the market.

According to a report published by the Germany Trade and Investment (GTAI) Organization, Germany’s healthcare market is number 1 in Europe by volume, number of patients, medical technology manufacturers, and healthcare providers. As per the report, Germany’s hospital industry is highly advanced, while healthcare spending in the country exceeded EUR 400 billion in 2019, and is growing further.

According to a report published by the PLOS Organization on 24th April 2020, in the adult German population, Chronic Kidney Disease (CKD) is estimated to have a prevalence between 2% to 7%, while a majority of CKD patients are classified as stage 3.

This is indirectly contributing to the rise in sales of serological transplant diagnostic equipment across the country.

Do Suppliers of Serological Transplant Diagnostic Equipment Need to Look at India?

India has emerged as another lucrative market for serological transplant diagnostics, and is expected to take its spot in the limelight for suppliers and manufacturers in this industry. Increase in cases of lung, heart, and kidney failure, coupled with steady growth of the healthcare & diagnostics industry is spurring growth in India.

According to a report titled “Chronic Kidney Disease in India”, published by the American Society of Nephrology on 7th May 2018, reported a prevalence of CKD in different regions across India ranges from 1% to 13%.

Recently, data from the International Society of Nephrology’s Kidney Disease Data Centre Study reported a prevalence of 17%, while the etiology of CKD varies considerably throughout India. These statistics give an idea regarding the upcoming opportunities in India for stakeholders in the serological transplant diagnostics space.

Category-Wise Insights

Which Product is Highly Sought-After for Serological Transplant Diagnostics?

According to Fact.MR, reagents & accessories, followed by systems, are dominating the global serological transplant equipment market in terms of product.

Reagents and accessories are an integral part of various types of serological transplant diagnostic tests such as blood type testing, Human Leukocyte Antigens (HLA) testing, and other serological tests, as they are highly useful and crucial for effective organ transplantation.

Which Transplantation Procedures Top the Application List?

Currently, rise in demand for serological transplant diagnosis is becoming more prevalent in applications such as kidney and liver transplantation. Increase in cases of kidney and liver damage is expected to further fuel the sales of manufacturers in this industry.

Some of the other key segments aiding market expansion in this category are heart and lung transplantation.

Rise in Demand from Hospitals to Bolster Market Growth

With steady expansion of hospitals, demand for serological transplant diagnostic equipment is surging around the globe. According to the European Commission (EC), the EU hospitals and healthcare industry is growing fast, while contributing to nearly 2% of EU’s total manufacturing workforce.

Other key distribution channels are blood banks & transplant centers, donor registries, and research laboratories.

Competitive Landscape

The global serological transplant diagnostics market is fragmented in nature and thriving on potential players. In order to capitalize on new opportunities, key market players are diversifying their product portfolios. For instance,

• Recently, Bag Health Care GmbH launched its wide range of serological transplant diagnostic solutions such as bag diagnostics microlymphocytotoxicity test, bag diagnostics histo trays, and others.
• Siemens Healthineers expanded its serological testing domains, including SARS-CoV-2 Testing in 2020, in order to increase its sales footprint.

Report Scope

Attribute	Details
Forecast Period	2021-2031
Historical Data Available for	2016-2020
Market Analysis	USD Million for Value
Key Regions Covered	North America Latin America Europe South Asia East Asia Middle East & Africa Oceania
Key Countries Covered	US Canada Germany U.K. France Italy Spain Poland Russia China Japan South Korea India Thailand Malaysia Vietnam Indonesia Australia New Zealand GCC Countries Turkey Northern Africa South Africa
Key Segments Covered	Product Application Distribution Channel Region
Key Companies Profiled	Becton Dickinson & Company ThermoFisher Scientific Inc. Bio-Rad Laboratories Inc. Agena Bioscience Inc. Avioq Inc. Bag Health Care GmbH Immucor Inc. Siemens Healthineers Produkte GmbH
Report Coverage	Market Forecasts Brand Share Analysis Competition Intelligence DROT Analysis Market Dynamics and Challenges Strategic Growth Initiatives

Market Segmentation by Category

By Product :

• Reagents & Accessories
• Systems

By Application :

• Kidney Transplantation
• Liver Transplantation
• Heart Transplantation
• Lung Transplantation
• Others

By Distribution Channel :

• Hospitals
• Blood Banks & Transplant Centres
• Donor Registries & Research Laboratories

By Region :

• North America
• Latin America
• Europe
• Middle East and Africa (MEA)
• East Asia
• South Asia
• Oceania